Učitavanje...
Interleukin-2-Inducible T-Cell Kinase Deficiency—New Patients, New Insight?
Patients with primary immunodeficiency can be prone to severe Epstein–Barr virus (EBV) associated immune dysregulation. Individuals with mutations in the interleukin-2-inducible T-cell kinase (ITK) gene experience Hodgkin and non-Hodgkin lymphoma, EBV lymphoproliferative disease, hemophagocytic lymp...
Spremljeno u:
| Izdano u: | Front Immunol |
|---|---|
| Glavni autori: | , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Frontiers Media S.A.
2018
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5951928/ https://ncbi.nlm.nih.gov/pubmed/29867957 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2018.00979 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|